miR-454 Reduces Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen by Simultaneously Targeting at RUNX3 and ER alphaHui Liu,Chenxi Xiang,Dongshen MaLABORATORY INVESTIGATION（2020）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
